Filing Details
- Accession Number:
- 0001209191-21-067391
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-02 06:30:09
- Reporting Period:
- 2021-11-30
- Accepted Time:
- 2021-12-02 06:30:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627810 | C Michael Donegan | 951 Yamato Road Suite 220 Boca Raton FL 33431 | Cao And Vp Of Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-30 | 115,000 | $0.00 | 129,158 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-30 | 29,790 | $0.54 | 99,368 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-11-30 | 115,000 | $0.00 | 115,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 115,000 | No | 4 | M | Direct |
Footnotes
- On November 30, 2021, the reporting person received 115,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on November 24, 2021.
- The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $0.4819 to $0.5503 for an average weighted sale price of $0.5353. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
- The RSUs vest in two equal installments on November 24, 2021 and November 24, 2022.
Billionaire Hedge Funds
